Transdermal delivery of the active enantiomer of ketorolac

Details Transdermal delivery of the active enantiomer of ketorolac Transdermal delivery of the active enantiomer of ketorolac

1995-06-06

1996-12-31

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

424449, A61K 3140, A61K 970

Patent

active

055894984

ABSTRACT:
The invention provides for the transdermal delivery of the active enantiomer of the analgesic ketorolac. Transdermal patches according to the invention are capable of delivering (-) ketorolac to a patient at therapeutically effective levels, at a flux rate of 20 .mu.g/cm.sup.2.hr or more. Patches for use in the present invention may be adhesive matrix, monolithic matrix, or liquid reservoir transdermal patches.

REFERENCES:
patent: 4089969 (1978-05-01), Muchowski et al.
patent: 4615699 (1986-10-01), Gale et al.
patent: 4624665 (1986-11-01), Nuwayser
patent: 4687481 (1987-08-01), Nuwayser
patent: 4818541 (1989-04-01), Sanderson
patent: 4898734 (1990-01-01), Mathiowitz et al.
patent: 4910205 (1990-03-01), Kogan et al.
patent: 4927687 (1990-05-01), Nuwayser
patent: 4943435 (1990-07-01), Baker et al.
patent: 4952402 (1990-08-01), Sparks et al.
patent: 4992445 (1991-02-01), Lawter et al.
patent: 5028435 (1991-07-01), Katz et al.
patent: 5049386 (1991-09-01), Eppstein et al.
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5091182 (1992-02-01), Ong et al.
patent: 5114946 (1992-05-01), Lawter et al.
patent: 5124157 (1992-06-01), Colley et al.
patent: 5519046 (1996-05-01), Noda et al.
Gusman et al., Chemical Abstracts 104(15): 129734n, 1986.
Brocks et al., Medline Abstract No. 93092511, 1992.
Yu, et al., "Percutanteous Absorption of Nicardipine and Ketorolac in Rehsus Monkeys," Pharmaceutical Research, vol. 5, No. 7, 1988, pp. 457-462.
Greenwald, "Ketorolac: An Innovative Non-Steroidal Analgesic," Drugs of Today, vol. 28, No. 1, 1992, pp. 41-61.
Baker, R. W. Controlled Release of Biologically Active Agents, John Wiley & Sons, NY, pp. 4-10 (1987).
Jamali et al. J. of Pharmaceutical Sciences 789 695-714 (1989).
Campbell, D. B. European J. of Drug Metabolism and Pharmacokinetics 15 109-125 (1990).
Guzman, et al. J. Med. Chem. 29 589-591 (1986).
Mroszczak et al. Clin. Pharmacology & Therapeutics 49 126 (1991).
Stinson C&EN 46-79 (Sep. 28, 1992).
Rowland & Tozer Clinical Pharmacokinetics: Concepts and Applications 2nd Ed. (1989) pp. 19-25.
Drayer Clinical Pharmacology & Therapeutics 40 No. 2 125 (1986).
Smith Pharmacology & Toxicology 65 321-331 (1989).
Ariens, et al. Biochemical Pharmacology 37 9-18 (1988).

Affiliated with

Also associated with

Rating

Transdermal delivery of the active enantiomer of ketorolac does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal delivery of the active enantiomer of ketorolac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery of the active enantiomer of ketorolac will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1142455